Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults

Journal of Human Hypertension

Volumn 21, Issue 3, 2007, Pages 231-238

  Malik, A R ^a   Sultan, S ^a   Turner, S T ^a   Kullo, I J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALBUMINURIA; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL TONE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CREATININE URINE LEVEL; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; GLUCOSE URINE LEVEL; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INVASIVE MEASUREMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS; URINALYSIS; VASCULAR DISEASE;

ALBUMINURIA; BRACHIAL ARTERY; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; MINNESOTA; MULTIVARIATE ANALYSIS; NITROGLYCERIN; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; VASODILATION;

EID: 33847069623     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002143     Document Type: Article

References (46)

1. Verdecchia P, Reboldi GP. Hypertension and microalbuminuria: The new detrimental duo. Blood Press 2004; 13: 198-211.
2. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325-1333.
3. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986-993.
4. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18: 645-654.
5. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 2003; 139: 901-906.
6. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223-228.
7. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
8. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
9. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.
10. Ibsen H, Olsen. MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198-202.
11. Pedrinelli R, Dell'Omo G, Penno G, Mariani M. Nondiabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med 2001; 6: 257-264.
12. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
13. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
14. Boerwinkle E. Multi-Center Genetic Study of Hypertension: The Family Blood Pressure Program (FBPP). Hypertension 2002; 39: 3-9.
15. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004; 164: 1313-1318.
16. Kullo IJ, Li G, Bielak LF, Bailey KR, Sheedy PF II, Peyser PA et al. Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. Mayo Glin Proc 2006; 81: 177-182.
17. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
18. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42: 291-296.
19. Hutchison AS, O'Reilly DS, MacCuish AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 1988; 34: 2010-2021.
20. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International brachial artery reactivity task force. J Am Coll Cardiol 2002; 39: 257-265.
21. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
22. Hartland A, Gosling P. Microalbuminuria: Yet another cardiovascular risk factor? Ann Clin Biochem 1999; 36: 700-703.
23. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: A critical review of basic concepts and perspective. Am J Kidney Dis 2002; 39: 899-919.
24. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
25. Yudkin JS. Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease. Ann Med 1996; 28: 433-438.
26. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319.
27. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 2001; 44: 593-601.
28. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 2004; 94: 294-299.
29. Yu Y, Sue L, Yu H, Wang C, Tang H. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diabetes Res Clin Pract 2004; 65: 95-104.
30. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction-the Hoorn Study. Kidney Int Suppl 2004; 66: S42-S44.
31. Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V. Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy. J Clin Endocrinol Metab 2006; 91: 31-35.
32. Meeking DR, Cummings MH, Thorne S, Donald A, Clarkson P, Crook JR et al. Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria. Diabet Med 1999; 16: 841-847.
33. Diercks GF, Stroes ES, van Boven AJ, van Roon AM, Hillege HL, de Jong PE et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. Atherosclerosis 2002; 163: 121-126.
34. Kathiresan S, Gona P, Larson MG, Vita JA, Mitchell GF, Tofler GH et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation 2006; 113: 938-945.
35. Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821-825.
36. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18.
37. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874.
38. Mehta JL. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J 1995; 129: 382-391.
39. Zhang X, Zhao SP, Li XP, Gao M, Zhou QC. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis 2000; 149: 19-24.
40. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123-127.
41. Yugar-Toledo JC, Bonalume Tacito LH, Ferreira-Melo SE, Sousa W, Consolin-Colombo F, Irigoyen MC et al. Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryltrinitrate stimulated vascular reactivity. Circ J 2005; 69: 1380-1385.
42. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
43. Higashi Y, Oshima T, Ozone R, Watanabe M, Matsuura H, Kajiyama G. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 1995; 25: 898-902.
44. Higashi Y, Oshima T, Ozone R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252-258.
45. Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946-951.
46. Gokce N, Holbrook M, Hunter LM, Palmisano J, Vigalok E, Keaney Jr JF et al. Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol 2002; 40: 761-765.